Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-dexamethasone for anterior uveitis
IRCT20190218042750N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexamethasone in cyclitis (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Best corrected visual acuity, Intraocular pressure and 2 more. Started Feb 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
cyclitis
Beyond the preview
Go deeper on IRCT20190218042750N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190218042750N1.